William L. Baker, PharmD

ARIZONA DIGESTIVE HEALTH PC

3707 N 7TH ST STE 305

Articles

Dronedarone: An antiarrhythmic agent for the management of atrial fibrillation and atrial flutter

February 01, 2009

Dronedarone, an investigational antiarrhythmic agent being studied for the management of AF and atrial flutter, has a pharmacologic mechanism of action that is similar to that of amiodarone, but dronedarone lacks an iodine moiety, which may result in less thyroid and pulmonary toxicity. Dronedarone is currently pending FDA approval; the agent was granted priority review in August 2008.